Table 3.
Evaluation of the quality of the studies analysed and the assessment of the risk of bias using JBI critical appraisal checklist for cohort studies
| Bayne 2021 [25] | Terrell 2009 [26] | Crews 2014 [27] | Banerjee 2017 [28] | Banerjee 2019 [28] | |
|---|---|---|---|---|---|
| Were the two groups similar and recruited from the same population? | Yes | Yes | Yes | Yes | Yes |
| Were the exposures measured similar to assign people to both exposed and unexposed groups? | Yes | Yes | Yes | Yes | Yes |
| Was the exposure measured in a valid and reliable way? | Yes | Yes | Yes | Yes | Yes |
| Were confounding factors identified? | Yes | Yes | Yes | Yes | Yes |
| Were strategies to deal with confounding factors stated? | Yes | Yes | Yes | Yes | Yes |
| Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)? | Yes | Yes | Yes | Yes | Yes |
| Was the outcomes measured in a valid and reliable way? | Yes | Yes | Yes | Yes | Yes |
| Was the follow-up time reported and sufficient to be long enough for outcomes to occur? | Yes | Yes | Yes | Yes | Yes |
| Was follow-up complete, and if not, were the reasons to loss to follow-up described and explored? | Yes | Yes | Yes | Yes | Yes |
| Were strategies to address incomplete follow-up utilized? | Yes | Yes | Yes | Yes | Yes |
| Was appropriate statistical analysis used? | Yes | Yes | Yes | Yes | Yes |